Clinical Trial Update: A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Amlodipine in Hypertensive Non Responders Patients [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 clinical trial evaluating the safety and efficacy of the aliskiren and amlodipine combination in hypertensive …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• NORVASC (amlodipine besylate)
• Tekturna (aliskiren)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED